Development and Evaluation of an Exercise Intervention for Prevention of Vertebral Osteoporosis and Deformity in Postmenopausal Women

December 8, 2020 updated by: Katherine Brooke-Wavell, Loughborough University

The Efficacy of a Resistance Band Exercise Intervention to Improve Vertebral Fracture Risk Facts in Post-menopausal Women

Osteoporotic fractures of the vertebrae (bones in the back) cause substantial pain and disability. Exercise could help to prevent these fractures by increasing bone strength and improving posture. Unfortunately, not all exercises strengthen bone. Exercises that do work (e.g. heavy weight lifting) are not popular with women at risk of osteoporosis. The investigators will develop a feasible exercise programme that can be done at a community centre or at home, using resistance bands. The investigators will involve women in designing the programme and incorporate strategies to support behaviour change. The investigators will then examine whether the programme improves bone density, posture or muscle strength in eighty women. Half the women, chosen at random, will take up exercise whilst the remaining half act as a control group. The investigators will take bone scans to determine bone density, and measure spinal curvature and strength, before and after the six- month programme. Findings will be useful in making recommendations as to which types of exercise increase spine bone density and will help to design future research on maximising vertebral strength. If significant benefits are seen, the investigators will develop resources such as booklets and videos so that the intervention can be widely available.

Study Overview

Detailed Description

Healthy, post-menopausal elderly women without other conditions restricting them from completing an exercise intervention. Inclusion criteria will be: Aged 60-80 and postmenopausal for at least 5 years, not taking/eligible for osteoporosis medication. Exclusion criteria will be: regular (>once per week) participation in high impact or high load resistance training, any disease or medication that contraindicates exercise or affects bone metabolism, meet UK criteria for pharmaceutical treatment of osteoporosis (will be referred to GP for treatment). The primary outcome measure will be AP lumbar spine (L1-4) BMD, measured by DXA using a GE Lunar iDXA densitometer. Secondary outcomes will include: BMD at femoral neck and lateral BMD of vertebra and hip structural parameters by DXA. Vertebral morphometry and dimensions, and total and regional body composition (bone, fat and lean masses), spinal curvature will be assessed from lateral DXA scans using statistical shape modelling (SSM) and the Cobb angle will be calculated as a measure of kyphosis, previous and current bone relevant physical activity will be assessed using a validated questionnaire, physical performance will be assessed using the Short Physical Performance Battery and functional mobility will be assessed using the Senior Fitness Test (SFT), peak force developed during exercises will be assessed by performing exercise using a resistance band of the current weight instrumented using a spring balance, postural sway will be assessed by measuring the movement of the centre of mass (COM), centre of foot pressure (COP), body segment through force platforms.

The intervention group will be asked to take up a six-month programme of muscle strengthening exercises using resistance bands. Exercises will be introduced through group sessions run three times per week, some of which could be substituted by home exercise supported by an exercise booklet and video. The intervention will consist of initial spinal extension and core strengthening exercises to ensure good posture and form (e.g. thoracic spine extension and abdominal exercise avoiding spinal flexion). Exercises that increased BMD will be adapted for resistance bands, initially at low intensity to allow development of good technique. Intensity will be increased gradually by employing bands of greater stiffness until participants can only complete 8 repetitions without a break. Once participants can attain 12 repetitions, intensity will be progressed by using a higher strength band. Participants will be advised in technique and progression at group sessions, to support transition to independent exercise by the end of the study.

The intervention will include a behaviour change component that considers capability, opportunity and motivation using the Behaviour Change Wheel framework by using the taxonomy of behaviour change interventions to identify the most appropriate strategies for facilitating behaviour change. The nature of the intervention considers the social and physical limitations to opportunity to exercise, and physical and psychological capability as identified in the qualitative phase by incorporating a group component to exercise and avoiding settings such as a gym. To accord with the practical and environmental factors identified, sessions will be offered at a variety of times of day. Explanations of safety of exercise with low BMD and purpose of the exercises in the group class and booklet/video will underpin knowledge aspects. Participants will be encouraged to be involved in goal setting and action planning. This will be supported using text reminders and motivational messages or other support strategies. Feedback in group sessions will also reinforce reflective motivation. Support and implementation strategies will be continuously reviewed based upon findings in initial participants. The control group will be asked to continue their usual exercise and dietary habits as if they were not participating in the study.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Loughborough, Leicestershire, United Kingdom, LE11 3TU
        • Donghyeon Seo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Aged 60-80 and postmenopausal for at least 5 years
  • Not taking/eligible for osteoporosis medication

Exclusion Criteria:

  • Regular (>once per week) participation in high impact or high load resistance training.
  • Any disease or medication or injury that contraindicates exercise or affects bone metabolism.
  • Meet UK criteria for pharmaceutical treatment of osteoporosis (will be referred to GP for treatment).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: High intensity resistance band exercise
Randomly assigned as exercise group, exercise intervention. This will be a progressive exercise programme with the aim being to participate three times per week, one in a group session and two in-home sessions.
A resistance band based exercise programme lasting six months
EXPERIMENTAL: Non resistance band exercise
Randomly assigned non-exercise group
Maintained usual physical activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in AP lumbar spine (L1-4) bone mineral density (g/cm2)
Time Frame: Baseline measurement and 6 month follow-up measurements
Lumbar spine bone mineral density measured by DXA using a GE Lunar iDXA densitometer
Baseline measurement and 6 month follow-up measurements

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in AP lumbar spine bone mineral density (g/cm2)
Time Frame: Baseline measurement and 6 month follow-up measurements
DXA scan: Measurement of lumbar spine bone mineral density (g/cm2)
Baseline measurement and 6 month follow-up measurements
Change in AP lumbar spine mineral content (g)
Time Frame: Baseline measurement and 6 month follow-up measurements
DXA scan: Measurement of lumbar spine mineral content (g)
Baseline measurement and 6 month follow-up measurements
Change in femoral neck bone mineral density (g/cm2)
Time Frame: Baseline measurement and 6 month follow-up measurements
DXA scan: Measurement of femoral neck bone mineral density (g/cm2)
Baseline measurement and 6 month follow-up measurements
Change in femoral neck bone mineral content (g)
Time Frame: Baseline measurement and 6 month follow-up measurements
DXA scan: Measurement of femoral neck bone mineral content (g)
Baseline measurement and 6 month follow-up measurements
Change in spinal curvature (°)
Time Frame: Baseline measurement, 3 months and 6 month follow-up measurements
Spinal curvature will be assessed from lateral DXA scans using the Cobb angle as a measure of kyphosis.
Baseline measurement, 3 months and 6 month follow-up measurements
Change in chair stand (sec)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Chair stand: Time taken to stand up and sit down as quickly as possible 5 times.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in gait speed (sec)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Timed walk (Gait speed): Time taken to walk 8-feet (2.44metres)
Baseline measurement, 3 months and 6 months follow-up measurements
Change in balance (sec)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Tandem balance: Ability to balance unsupported for 10 seconds with feet in three different positions (i.e side by side stands [feet together], semi tandem and full tandem).
Baseline measurement, 3 months and 6 months follow-up measurements
Change in timed up and go (sec)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Timed up and go: Time taken to rise from a chair, walk three metres away, turn and walk back to the chair and sit down again.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in back scratch (cm)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Back scratch: Distance between hands when reaching both arms behind the back: one arm upwards, one down.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in arm curls (rep)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Arm curls: Number of bicep curls that can be completed in 30s with a 2.25kg dumbbell.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in Posture sway (mm)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Postural sway will be assessed by measuring the movement of the centre of foot pressure (COP) using a force platform. Measurements will be repeated 30 seconds in four conditions: eyes open, firm surface eyes closed, firm surface eyes open, compliant surface eyes closed, compliant surface.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in Trunk extensor strength (N)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Trunk extensor strength will be using a handheld dynamometer. Participant will be asked to lie prone on a couch and push upward against the dynamometer which is mounted on a custom built frame. Participants will be allowed three attempts and the maximum force recorded.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in Trunk extensor endurance (sec)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Back endurance in trunk extension will be assess with the participant lying prone. Participants will be asked to lift the upper body off the surface and hold for as long as possible. The time will be recorded.
Baseline measurement, 3 months and 6 months follow-up measurements
Change in peak force (kg)
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
Peak force developed during exercises will be assessed by performing exercise using a resistance band of the current weight instrumented using a spring balance.
Baseline measurement, 3 months and 6 months follow-up measurements
A health screening questionnaire
Time Frame: Baseline measurement
A health screening questionnaire will be used to assess suitability for the study
Baseline measurement
A PAR-Q questionnaire
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
A PAR-Q questionnaire will be used to check readiness to exercise
Baseline measurement, 3 months and 6 months follow-up measurements
A CaQ Calcium intake questionnaire
Time Frame: Baseline measurement, 3 months and 6 months follow-up measurements
A CaQ Calcium intake questionnaire will be used to estimate dietary calcium
Baseline measurement, 3 months and 6 months follow-up measurements

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2018

Primary Completion (ACTUAL)

December 31, 2019

Study Completion (ACTUAL)

January 31, 2020

Study Registration Dates

First Submitted

June 9, 2020

First Submitted That Met QC Criteria

December 8, 2020

First Posted (ACTUAL)

December 9, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 9, 2020

Last Update Submitted That Met QC Criteria

December 8, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoporosis

Clinical Trials on A resistance band exercise programme

Subscribe